Stephen P. Squinto is EVP & Chief Global Ops. Officer at ALEXION PHARMACEUTICALS INC (ALXN). They have made 44 open-market trades across 2 companies since 2006, most recently 2022-05-19.
CIK 0001231954
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2019, against 43 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SWTX | SELL | 2021-04-27 | 2021-04-28 | $76.19 | $2.9M | -12.0% | +4.6% | +8.4% |
| SWTX | SELL | 2021-04-14 | 2021-04-19 | $75.02 | $197K | +8.1% | +8.9% | +12.2% |
| SWTX | BUY | 2019-09-17 | 2019-09-19 | $18.00 | $5.0M | -25.9% | -17.6% | +29.9% |
| ALXN | SELL · 10b5-1 | 2014-10-27 | 2014-10-28 | $188.58 | $1.1M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2014-10-03 | 2014-10-07 | $172.41 | $1.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-09-24 | 2014-09-26 | $159.50 | $12K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-08-04 | 2014-08-05 | $157.42 | $262K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-02-06 | 2014-02-10 | $158.04 | $1.1M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-02-03 | 2014-02-05 | $155.12 | $5.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-01-29 | 2014-01-31 | $133.31 | $149K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2013-11-04 | 2013-11-05 | $123.87 | $1.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-10-28 | 2013-10-30 | $124.06 | $5.1M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-09-24 | 2013-09-26 | $112.54 | $34K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-09-13 | 2013-09-17 | $114.37 | $114K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-08-05 | 2013-08-07 | $116.87 | $100K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2013-08-02 | 2013-08-02 | $115.33 | $1.6M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-07-30 | 2013-08-01 | $110.86 | $124K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2013-07-12 | 2013-07-16 | $119.90 | $2.2M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2013-07-01 | 2013-07-03 | $94.97 | $4.2M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2013-04-29 | 2013-05-01 | $98.96 | $3.6M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-03-08 | 2013-03-12 | $91.36 | $1.8M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-02-04 | 2013-02-06 | $95.68 | $246K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-01-28 | 2013-01-30 | $94.41 | $140K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2012-07-27 | 2012-07-31 | $107.26 | $10.9M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2012-07-09 | 2012-07-11 | $100.44 | $5.0M | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.